title: Review of new guidelines for the management of glucocorticoid induced osteoporosis.
abstract: The chronic use of glucocorticoids results in osteoporosis. Several sets of guidelines have been published on the management of glucocorticoid induced osteoporosis (GIO). These guidelines vary on their focus and highlight different aspects of the current concepts in the management of GIO. In this current article, we summarize recent guidelines for management of GIO and highlight similarities and differences as well as address some of the controversies generated by these guidelines.
authors.affiliation: Clinical Instructor, Division of Endocrinology, Clinical Associate Prof. Division of Rheumatology, University of California, Los Angeles, CA, USA, swamy.venuturupalli@gmail.com.
authors.forename: Swamy R
authors.initials: SR
authors.lastname: Venuturupalli
authors.forename: Wendy
authors.initials: W
authors.lastname: Sacks
mesh_terms: D000465:Algorithms; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D012216:Rheumatic Diseases / Q000188:drug therapy; D014807:Vitamin D / Q000627:therapeutic use
chemical_list: D004164:Diphosphonates; D005938:Glucocorticoids; D014807:Vitamin D; D002118:Calcium